Towards a gene therapy for cystic fibrosis lung disease

Bibliography

• ROMMENS JM, IANUZZI MC, KEREM B et al.: Identification of the cystic fibrosis gene: chromosome walking and jumping. Science (1989) 245:1059–1065.
   PubMed Web of Science ®Google Scholar
• RIORDAN JR, ROMMENS JM, KEREM B et al: Identification of the cystic fibrosis gene: cloning and characterisation of complementary DNA. Science (1989) 245:1066–1073.
   PubMed Web of Science ®Google Scholar
• BOAT TF, WELSH MJ, BEAUDET AL: Cystic fibrosis. Scriver CR, Beaudet AL, Sly WS, Valle D (Eds.), McGraw Hill, New York (1989)2649–2680.
   Google Scholar
• QUINTON P: Cystic fibrosis: a disease in electrolyte transport. FASEB J (1990) 4:2709–2717.
   PubMed Web of Science ®Google Scholar
• JOHNSON LG: A perspective on gene therapy for cystic fibrosis. Exp. Opin. Invest. Drugs (1996) 5(0:29–42.
   Google Scholar
• ZABNER J, COUTURE LA, GREGORY RJ et al: Adenovirus-mediated gene transfer transiently corrects the chlo-ride transport defect in the nasal epithelia of patients with cystic fibrosis. Cell (1993) 68:207–216.
   Google Scholar
• CRYSTAL RG, MCELVANEY NG, ROSENFELD MA et al.: Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Gen. (1994) 8:42–51.
   PubMed Web of Science ®Google Scholar
• CRYSTAL RG, JAFFE A, BRODY S et al: A Phase I study, in cystic fibrosis patients, of the safety, toxicity, and bio-logical efficacy of a single administration of a replica-tion-deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung. Human Gene Ther. (1995) 6:643–666.
   PubMed Web of Science ®Google Scholar
• KNOWLES MR, HOHNEKER K, ZHOU Z et al.: A controlled study of adenoviral vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. New Engl. J. Med. (1995) 333:823–831.
   PubMed Web of Science ®Google Scholar
• CAPLEN NJ, ALTON EWFW, MIDDLETON PG et al.: Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Med. (1995) 1:39–46.
   PubMed Web of Science ®Google Scholar
• GILL DR, SOUTHERN KW, MOFFORD KA et al.: A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther. (1997) 4:199–209.
   PubMed Web of Science ®Google Scholar
• JOHNSON LG, OLSEN JC, SARKADI B et al: Efficiency of •gene transfer for restoration of normal airway epi-thelial function in cystic fibrosis. Nature Gen. (1992) 2:21-25. Quantitated the percentage of transduced CF airway epithelial cells expressing CFTR cDNA required for 'correction' of a CF epithelial monolayer in vitro.
   Google Scholar
• JOHNSON LG, BOYLES SE, WILSON JM, BOUCHER RC: •Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibro-sis airway epithelial cells. J Clin. Invest. (1995) 95:1377–1382.
   Google Scholar
• BOUCHER RC: Current status of CF gene therapy. Trends •Gen. (1996) 12(3):81–84.
   Google Scholar
• GRUBB BR, PICKLES RJ, YE H et al.: Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature (1994) 371:802-806. First report on the resistance of the respiratory epithelium to adenoviral transduction.
   Google Scholar
• PICKLES RJ, BARKER PM, YE H, BOUCHER RC: Efficient adenovirus-mediated gene transfer to basal but notcolumnar cells of cartilaginous airway epithelia. Hu-man Gene Ther. (1996) 7:921-931. Identified the well-differentiated columnar airway epithelial cells as the reason why adenoviral-mediated gene transfer to the respiratory epithelium is inefficient.
   Google Scholar
• ROSENFELD MA, SIEGFRIED W, YOSHIMURA K et al.:
   Google Scholar
• Adenovirus-mediated transfer of a recombinant ai-an-titrypsin gene to the lung epithelium in vivo. Science (1991) 252:431-434. First paper describing gene transfer to the lung in viva
   Google Scholar
• ROSENFELD MA, YOSHIMURA K, TRAPNELL BC et al.: In vivo transfer of the human cystic fibrosis transmem-brane conductance regulator gene to the airway epithe-IMm. Cell (1992) 68:143-155. First paper describing delivery of CFTR cDNA to the lung in vivo.
   Google Scholar
• MASTRANGELI A, DANEL C, ROSENFELD MA et al.: Diver-sity of airway epithelial cell targets for in vivo recombi-nant adenovirus-mediated gene transfer. J. Clin. Invest. (1993) 91:225–234.
   PubMed Web of Science ®Google Scholar
• GOLDMAN MJ, WILSON JM: Expression of (45 integrin is necessary for efficient adenovirus-mediated genetransfer in the human airway. J Vim]. (1995) 69:5951-5958. Describes the lack of adenovirus receptors on the lumen of human respiratory epithelium.
   Google Scholar
• PICKLES RJ, RANDELL SH, MATSUI H, MCCARTY D, BOUCHER RC: A low rate of internalisation is responsi-ble for inefficient adenoviral-mediated gene transfer to the well differentiated respiratory epithelium. J. Vim]. (Submitted).
   Google Scholar
• BERGELSON JM, CUNNINGHAM JA, DROGUETT G et al.:
   Google Scholar
• Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science (1997) 275:1320-1323. Cloning and functional analysis of an attachment receptor for the adenovirus.
   Google Scholar
• HONG SS, KARAYAN L, TOURNIER J, CURIEL DT, BOU- LANGER PA: Adenovirus type 5 fiber knob binds to MHC class I alpha 2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO J (1997) 16:2294-2306. Identification of an attachment receptor for the adenovirus.
   Google Scholar
• WICKHAM TJ, MATHIAS P, CHERESH DA, NEMEROW GR: Integrins 0303 and oc,135 promote adenovirus internali-sation but not virus attachment. Cell (1993) 73:309-319. Identification of adenoviral secondary receptors that are involved with internalisation of the virus into the cell.
   Google Scholar
• WICKHAM TJ, SEGAL DM, ROELVINK PW et al.: Targeted adenovirus gene transfer to endothelial and smoothmuscle cells by using bispecific antibodies. J. Virol (1996) 70(10):6831–6838.
   Google Scholar
• DOUGLAS JT, ROGERS BE, ROSENFELD ME et al: Targeted gene delivery by tropism-modified adenoviral vectors. Nature Biotechnol. (1996) 14:1574–1578.
   Google Scholar
• WICKHAM TJ, ROELVINK PW, BROUGH DE, KOVESDI I: Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell-types. Nature Biotechnol. (1996) 14:1570–1573.
   Google Scholar
• WICKHAM TJ, CARRION ME, KOVESDI I: Targeting of •adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-spe-cific peptide motifs. Gene Ther. (1995) 2:750–756.
   Google Scholar
• KRASNYKH VN, MIKHEEVA GV, DOUGLAS JT, CURIEL DT: Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J Virol (1996) 70(10)6839–6846.
   Google Scholar
• MICHAEL SI, HONG JS, CURIEL DT, ENGLER JA: Addition •of a short peptide ligand to the adenovirus fiber protein. Gene Ther. (1995) 2:660–668.
   Google Scholar
• HARRIS JD, LEMOINE NR: Strategies for targeted gene therapy. Trends Gen. (1996) 12 (10):400–405.
   PubMed Web of Science ®Google Scholar
• Vector Targeting Strategies for Therapeutic Gene DeliveryCold Spring Harbor, New York, USA (14–16 March 1997).
   Google Scholar
• BARRY MA, DOWER WJ, JOHNSTON SA: Toward cell-tar- •geting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage li- braries. Nature Med. (1996) 2:299–305.
   Google Scholar
• PASQUALINI R, RUOSLAHTI E: Organ targeting in vivo •using phage display libraries. Nature (1996) 380:364–346.
   Google Scholar
• WILSON JM: Gene therapy for cystic fibrosis: challenges and future directions. J. Clin. Invest. (1995) 96:2547–2554.
   PubMed Web of Science ®Google Scholar